Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
05/2003
05/14/2003CN1416819A Tincture for treating psoriasis and its prepn
05/14/2003CN1108160C Medicine for curing stomatocace and its preparation method
05/14/2003CN1108150C Method and composition for increasing calcium uptake
05/14/2003CN1108110C Composition comprising viscosity modulating polymer material and its use
05/13/2003US6562872 Emulsion of perfluoroorganic compounds for medical purposes, a process for the preparation thereof and methods for treating and preventing diseases with the use thereof
05/13/2003US6562870 treatment of AIDS-associated non-Hodgkin's lymphoma by administering gallium nitrate in a pharmaceutically acceptable vehicle.
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562855 Comprises a formulation. The formulation comprises an NMDA antagonist and an alpha-2 adrenergic agonist. In a preferred aspect, there is provided an improved anaesthetic comprising an NMDA antagonist and an alpha-2 adrenergic agonist.
05/13/2003US6562378 Nutritional supplement for adolescents
05/13/2003US6562336 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/13/2003CA2127114C A composition for the biological stimulation and correction of the phenotype of an organism and a method for treating the same
05/08/2003WO2003037383A1 An antineoplastic- dendritic polymer drug delivery system
05/08/2003WO2003037382A1 Low concentration of peroxide for treating or preventing vaginal infections
05/08/2003WO2003037300A1 Gastric raft composition
05/08/2003WO2003037298A2 Bowel cleansing agent
05/08/2003WO2003037297A2 Photosensitizer functionalised nanoparticles
05/08/2003WO2003037286A1 Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis
05/08/2003WO2003014128A3 Tumour inhibiting cerium compounds
05/08/2003WO2003005955A3 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
05/08/2003WO2002094377A3 Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension
05/08/2003WO2002069985A3 Immune response potentiation
05/08/2003US20030087960 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
05/08/2003US20030087894 Vitronectin receptor antagonist
05/08/2003US20030087861 Administering mixture of antibody and drug; cancer sensitivity
05/08/2003US20030087839 Combined preparations comprising morpholine anthracyclines and anticancer agent
05/08/2003US20030087830 Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof
05/08/2003US20030087427 Method and apparatus for delivering oxygen to cells
05/08/2003US20030086980 Method for the suppression of visceral pain by regulating T type calcium channel
05/08/2003US20030086977 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
05/08/2003US20030086965 Combination chemotherapy
05/08/2003US20030086964 Methods and compositions for polyene antibiotics with reduced toxicity
05/08/2003CA2465401A1 Photosensitizer functionalised nanoparticles
05/07/2003EP1308155A2 Injectable solution containing a colloid of iron and shark cartilage-derived chondroitin sulfate
05/07/2003EP1307209A1 Cardioplegic solution
05/07/2003EP1307208A1 Use of co for treating inflammation of upper airways or bronchi
05/07/2003EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/07/2003EP1307180A1 A method of preparing a pharmaceutical composition
05/07/2003EP1263447A4 Optically-active nanoparticles for use in therapeutic and diagnostic methods
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP0804247B1 Selenium conjugates for the preparation of free radical pharmaceuticals
05/07/2003CN1416322A Diabetic nutritionals
05/07/2003CN1415375A Ointment of Chinese traditional medicine for curing fever and cough
05/07/2003CN1415353A Formula of Chinese herbal medicine for curing lithiasis
05/07/2003CN1415346A Oral liquid for nephrosis
05/07/2003CN1415322A Externally-used paste for curing dermatitis
05/07/2003CN1415311A Novel preparation of ferrisodium pyrophosphate
05/07/2003CN1415310A Nano selenium of chitin and its preparation method
05/07/2003CN1415309A Nano selenium of Melatonin and its preparation method
05/07/2003CN1415308A Nano selenium of amino acid and its preparation method
05/07/2003CN1107517C Antiabortifacient for treating acyesis and sterility and its preparing process
05/07/2003CN1107515C Prepn. of external-applied medicine for mastoproliferation
05/07/2003CN1107510C Burn and scald treating medicine and its prepn.
05/07/2003CN1107499C Nitric oxide donor compsns. and method for treating anal disorders
05/06/2003US6559190 Treating a mammal for neurointoxication, wherein said neurointoxication is caused by an excess of neurotransmitter in said mammal, said method comprising treating said mammal with a xenon-containing gas in an amount effective to reduce
05/06/2003US6559139 Combination chemotherapy
05/06/2003US6558711 Composition and method for reducing the risk of carcinogenesis
05/06/2003US6558710 Zinc oxide, its hydrated complex with glycine or lycine and free anhydrous glycine; healing skin; minimizing irritation without loss of efficacy
05/06/2003US6558694 Zinc chloride unit dose packaging, applicator, and method of use in treating cancer and other skin diseases
05/06/2003US6558667 Therapy of patient suffering from a renal failure progressed to a stage at which an initiation of a dialysis therapy is required by combining a peritoneal dialysis and an administration of a spherical carbon
05/06/2003US6558666 Chromium-containing carbohydrase enzyme food supplement composition
05/06/2003US6558656 Oral and topical compositions and methods related thereto in the treatment of acne
05/06/2003US6558650 Enhancement of cellular gallium uptake
05/02/2003EP1306083A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
05/02/2003EP1305051A2 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
05/02/2003EP1305018A1 Method and compositions for prevention and/or treatment of diabetes and glucose modulation
05/02/2003EP1305004A1 Embolization using carbon coated particles
05/02/2003EP1200064B1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip
05/02/2003EP0973485B1 Cosmetic and dermatological agent with a hard-magnetic particle base
05/02/2003EP0939613B1 Mouthwash comprising calcium and phosphate ions in supersaturated solution
05/01/2003WO2003035698A1 Method for resistance of epilepsy by suppressing the function of alpha 1g protein
05/01/2003WO2003035108A1 Immunopotentiators in thermotherapy for cancer
05/01/2003WO2003035084A1 Superfine aqueous dispersion of noble metal for head massage
05/01/2003WO2003035078A1 Combined use of catalytic antioxidants and glutathion or lipoic acid
05/01/2003WO2003035029A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/01/2003WO2003035027A1 Chewable tablet containing lysine
05/01/2003WO2003026680A3 Method and topical formulation for treating skin conditions associated with aging
05/01/2003WO2003003981A3 Compositions for improving mental performance
05/01/2003WO2002060458A3 Compositions and method of tissue superoxygenation
05/01/2003WO2002043739A3 Dermatological formulations containing clindamycin and a zinc-salt
05/01/2003WO2002013873A3 P97-active agent conjugates and their methods of use
05/01/2003WO2002000244A3 Protein mixtures for wound healing
05/01/2003US20030083739 For treating vascular in-stent restenosis; drug delivery
05/01/2003US20030083610 Compositions and method of tissue superoxygenation
05/01/2003US20030083308 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses
05/01/2003US20030082685 Chemotherapeutic induction of egr-1 promoter activity
05/01/2003US20030082223 Mixture contains flow control agent and thickener
05/01/2003US20030082133 Biocide treating anthrax; highly stable and safe for exposure to human skin; antibiological warfare agents, for surface coatings
05/01/2003CA2464976A1 Superfine aqueous dispersion of noble metal for head massage
04/2003
04/30/2003CN1414863A Treatment of DNA viral infections
04/30/2003CN1414859A Combinations for treatment of DNA viral infections
04/30/2003CN1414846A Topical anti-microbial compositions
04/30/2003CN1413704A Huafeng pill
04/30/2003CN1413662A Decoction for positive reaction of hepatitis B transformation to negative
04/30/2003CN1413640A Chinese medicine composition for treating enteritis
04/30/2003CN1413627A Medicine for treating dematosis
04/30/2003CN1413595A Mineralized liquid for prevention of dental caries
04/30/2003CN1413594A Medicine for prevention and curing reangiostenosis
04/30/2003CN1413593A Medicine for curing dermatosis
04/30/2003CN1413592A Ointment for curing multiple dermatosis
04/30/2003CN1413591A Oxygen-riched transfusion
1 ... 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 ... 563